The length and complexity of tuberculosis (TB) therapy, as well as the propensity of Mycobacterium tuberculosis to develop drug resistance, are major barriers to global TB control efforts. M. tuberculosis is known to have the ability to enter into a drug-tolerant state, which may explain many of these impediments to TB treatment. We have identified a novel mechanism of genetically encoded but rapidly reversible drug-tolerance in M. tuberculosis caused by transient frameshift mutations in a homopolymeric tract (HT) of seven cytosines (7C) in the glpK gene.
SIGNIFICANCE
The ability of M. tuberculosis to survive during prolonged treatment has been attributed to either transient stress responses or fixed heritable drug-resistance producing mutations. We show that phase-variation in the M. tuberculosis glpK gene represents a third type of resistance mechanism. The ability of these glpK mutants to grow slowly and then rapidly revert suggests that these transiently-heritable changes may also explain how a hidden population of drugtolerant bacteria develops during TB treatment. As a genetically trackable cause of drugtolerance, M. tuberculosis glpK mutants provides a unique opportunity to study these phenomena at a cellular and mechanistic level. These mutants could also be used for developing drugs that target tolerant populations, leading to more rapid and effective TB treatments.
INTRODUCTION
Despite decades of control efforts, tuberculosis (TB) remains the leading cause of death from an infectious disease (1) . The length and complexity of TB therapy is a major barrier to TB control. Drug-susceptible TB must be treated with multiple drugs, usually for 6 months, and multidrug-resistant TB must be treated for at least 9 months (2, 3) . Relapses remain fairly common despite these regimens (4) (5) (6) (7) . Many of these clinical phenomena can likely be attributed to the ability of Mycobacterium tuberculosis to enter into a tolerant state when exposed to drugs, hypoxia, nutritional deprivation, or host defense mechanisms during human infections that renders them temporarily drug-resistant (8) (9) (10) . This transient "phenotypic" drug-resistance is not thought to be caused by genetic changes associated with new heritable drug-resistance but has instead been attributed to reversible transcriptional and metabolic changes. A number of in vitro studies have confirmed that M. tuberculosis can become transiently drug resistant when cultured under growth-limiting conditions, including drug-treatment (11) (12) (13) . Evidence for the development of reversible phenotypic drug-resistance during human TB treatment includes the observation that most patients who relapse after treatment for drug-susceptible TB remain infected with the same fully drug-susceptible strain (14) (15) (16) . M. tuberculosis that has been cultured from apparently latent, closed and encapsulated lesions of patients undergoing TB treatment has also been found to be drug-susceptible (17) .
Phase variation is an adaptive mechanism that mediates reversible switching "on" and "off" of a gene by genotypic changes such as DNA methylation, homologous recombination, DNA rearrangement, or insertions/deletions in short sequence repeats or homopolymeric tracts (HTs) located within the promoter region or the coding sequence of a gene(18). Reversible frameshift mutations in HTs are a result of slipped-strand mispairing errors during replication and are well documented in many bacterial species (19) , with a high rate of HT variants observed in species with DNA mismatch repair (MMR) deficiency (20) . M. tuberculosis also lacks a recognizable MMR system (21, 22) . This suggests that the poly-G:C and poly-A:T tracts identified in the M. tuberculosis genome (21) may be susceptible to reversible insertion and deletion mutations during replication.
Here, we describe a novel mechanism of drug-tolerance that is caused by genetically encoded but rapidly reversible mutations in the 7C HT of the glpK gene in M. tuberculosis.
These mutations produce small colony and morphological variants that have reduced susceptibility to drugs, but unlike classical drug-tolerance or persistence, are expressed as a transiently heritable trait. We propose that GlpK phase variability may account for much of the clinical and microbiological observations associated with persistence and relapse TB in humans.
Results
Small colonies with altered morphology are detectable in clinical M. tuberculosis strains. We examined cultures of 26 drug susceptible (23) Fig. 1C ), C71-LC had a 3C insertion in a 7C homopolymeric tract (HT) (M. tuberculosis, nucleotide 566 to 572) of glpK. In contrast, the C71-SC sequence contained both 3C and 4C insertions in the same 7C HT, indicating a sub-strain mixture within the colony. The 3C insertion resulted in a GlpK192Gly insertion that preserved the glpK open reading frame; however, the 4C insertion increased the size of the 7C HT to 11C and produced a glpK frameshift. We noted similar mutational differences between the LCs and SCs of the multidrug-resistant strain TDR193. WGS of the LC (TDR193-LC) and the SC (TDR193-SC) sequences of strain TDR193 only identified mutations in glpK and rpoC (Table 1 ). TDR193-LC had wild-type glpK and a nonsynonymous mutation in rpoC. Mutations in rpoC have been previously described as compensatory for the rpoB mutations associated with rifampicin resistance (25) and this mutation was not investigated further. TDR193-SC had a single C insertion in the glpK 7C HT causing a frameshift (Table 1 and Fig. 1C ). We then sequenced this glpK hotspot in 94 additional M. tuberculosis clinical isolates randomly selected from the TDR-TB strain bank to represent a broad range of susceptibility profiles as well as geographic diversity(24) (SI Appendix, Table S1 ). The 7C HT was wild-type in 68, had a 1C insertion in 10, and showed a mixture of wild-type and 1C insertions in 16.
High frequency reversions among clinical glpK mutants. To determine whether
clinical glpK SC frameshift mutants revert to normal colony size, we cultured TDR193-SC to stationary phase and plated the culture on glycerol containing agar to identify LCs. TDR193-SC cultures reverted to LC morphology at high frequency both in the presence or absence of glycerol in liquid medium (2.9 10 -2 ±3.0 10 -2 in 7H9 without glycerol vs 1.7 10 -2 ±1.1 10 -2 in 7H9 with glycerol). We also performed serial passage of C71-SC, C71-LC, TDR193-SC and TDR193-LC single colonies in the absence of glycerol. Both C71-LC and C71-SC showed a mixture of small and large colonies in just 2 passages ( Fig. 1D and 1E ), perhaps because of the instability of the large 10C and 11C glpK HT regions in these strains. In contrast, for TDR193, the SC (TDR193-SC) reverted to LC in 4 passages ( Fig. 1F -G) but the LC (TDR 193-LC) was stable for 12 passages (Fig. 1H ). WGS of one C71-SC colony that reverted to a LC phenotype (C71-SC-RevLC) revealed a deletion of 1C in the glpK HT, reducing the 11C HT to 10C. WGS of two TDR193-SC colonies that reverted to a LC phenotype revealed either a deletion of 1C in the glpK HT (TDR193-SC-RevLC9), reducing the 8C HT back to 7C as exists in the H37Rv reference strain, or the insertion of an additional 2C in the glpK HT (TDR193-SC-RevLC1) increasing the HT to 10C (Table 1 and Fig. 1C ). Thus, each SC to LC mutant re-established the correct glpK gene open reading frame. No other new mutations were detected in the genomes of the revertants. Due to the high frequency of C71-SC and C71-LC reversions, compared to TDR193 variants, we did not perform any further experiments with C71 variants. Given the role of GlpK in glycerol metabolism, we cultured TDR193-SC, TDR193-LC, and TDR193-SC-RevLCs in media with or without glycerol supplementation. All strains had similar growth rates in liquid media (SI Appendix, Fig. S1A ) and equal colony sizes on solid media (SI Appendix, Fig.   S1B ) in the absence of glycerol. However, in the presence of glycerol, strains with a functional glpK (TDR193-LC, TDR193-SC-RevLC1, and TDR193-SC-RevLC9) had improved growth in liquid media (SI Appendix, Fig. S1A ) and produced larger colonies on solid media than TDR193-SC (SI Appendix, Fig. S1B ). These results demonstrate that clinical M. tuberculosis strains frequently generate glpK 7C HT frameshift-variants that have a slower growth capacity under certain culture conditions and have the ability to rapidly revert to higher growth patterns by reestablishing a correct open reading frame.
M. tuberculosis acquires frameshift mutations in the 7C HT of glpK during murine
infections. We studied glpK mutant generation in vivo by infecting C56BL/6 mice with a low dose of M. tuberculosis strain HN878 via aerosol. One group of mice were not treated with any anti-tuberculars, and a second group received 100 mg/kg of Moxifloxacin (MXF) to simulate a human dose equivalent for one week ( Fig. 2A ). SC cells appeared to spontaneously arise, or to be selected for during infection and treatment ( Fig. 2B ). SCs were undetectable in pre-infection cultures of HN878. However, by week 7 post infection, SCs comprised 9% (± 5%) of the CFU recovered from the lungs of untreated control mice and 62% (± 9%) of the CFU recovered from the lungs of MXF treated mice (p=0.002) ( Fig. 2C ). WGS of 1 SC (named HN878-SC) randomly picked from lung cultures of untreated mice and 3 LCs (HN878-XM4-LC1, HN878-XM4-LC2, and HN878-XM4-LC3) and 3 SCs (HN878-XM4-SC4, HN878-XM4-SC5, and HN878-XM4-SC6) randomly picked from lung cultures of MXF treated mice was performed. Compared to the parental HN878 strain, no mutations were detected in all 3 LCs genome sequences. In contrast, all 4 SCs had a 1C insertion in the 7C HT of glpK (Fig. 1C ), except for one SC (HN878-XM4-SC4) that also had a ΔC44 frameshift mutation in Rv0452 and a synonymous Gly157Gly mutation in purM. To confirm the presence of glpK frameshift mutations in other SCs, we sequenced the glpK 7C HT in another 27 randomly picked SCs (12 from untreated and 15 from the MXF treated group) and 20 LCs (11 from untreated and 9 from the MXF treated group). All (Table 1) . Despite these similarities, the INH MIC of TDR193-SC was 2-fold higher (5 µg/ml) than the MIC of TDR193-LC and TDR193-SC-RevLC9 (2.5 µg/ml) ( Table 2 ). On the other hand, all variants had the same MICs for moxifloxacin (MXF), RIF, and EMB. However, the small colony TDRR193-SC had a 5 and 22-fold relative survival advantage measured by colony counts on sub-MIC concentrations of either MXF (0.1 µg/ml) or EMB (8 µg/ml), respectively, compared to LCs TDR193-SC-RevLC9 and TDR193-LC (Fig. 3A) . The SC to LC revertant strain, TDR193-SC-RevLC9, had an intermediate survival advantage between the TDR193-LC and TDR193-SC. These differences at sub-MIC concentrations were only observed in the presence of glycerol. Next, we performed MIC experiments using a fully drug-susceptible HN878-SC strain isolated from our mouse study described above. An LC HN878 colony (HN878-LC) was used as a control after we had confirmed that this strain contained a wild type glpK gene. Both strains were isolated from the same lung of an infected mouse that had not been treated with MFX. These HN878 strains showed similar growth in media containing various concentrations of oleic acid (free fatty acid) or glyceryl trioleate (triglyceride derived from glycerol and three units of oleic acid, TAG), except in the presence of free glycerol where HN878-LC showed a more rapid growth rate (SI Appendix, Fig. S2A-B ). HN878-SC and HN878-LC also had the same MICs for INH, RIF, EMB, and MXF, (Table 2 ). However, HN878-SC exhibited a 3 to 100-fold growth advantage, as measured by CFU counts, on sub-MIC concentrations of each of these drugs in the presence of glycerol, compared to HN878-LC ( Fig.   3B ). Finally, we created clean glpK knock out mutants in M. tuberculosis strain H37Rv RIF and MXF compared to the same strains plated on solid media without drugs (Fig. 3F ). The reversible SC phenotype that we observed in three different M. tuberculosis strains was not limited to the M. tuberculosis sensu stricto but was also observable in M. bovis BCG (BCG) (SI Appendix, Text S1 and Fig. S3 ).
Small colony glpK frameshift mutants are tolerant to supra-MIC concentrations of
anti-tuberculosis drugs and hydrogen peroxide. We tested the extent to which SC glpK mutants exhibit a typical tolerant-like phenotype (26, 27) . Performing time-kill studies, we found that the HN878-SC (glpK mutant) had delayed killing compared to HN878-LC cultures incubated with either 0.4µg/ml of MXF (4X the MIC) or 1µg/ml of INH (20X the MIC) ( Fig. 4A-C). When incubated in MXF, the SC showed a 14-fold increase in survival on day 3 (p<0.01) and a 12-fold increase on day 5 (p<0.01). When incubated with INH, the SC showed a 2.84-fold increase in survival on day 1 (p<0.01) and a 2.72-fold increase on day 3 (p=0.05), compared to HN878-LC (glpK WT), in the presence of glycerol. We also tested the susceptibility of HN878-SC to the oxidative stress-inducing agent hydrogen peroxide. The HN878-SC was significantly more resistant to hydrogen peroxide (175mM), in the presence of glycerol, compared to HN878-LC ( Fig. 4D ).
Transcriptional profiling of M. tuberculosis glpK 7C frameshift mutants. To identify altered transcriptomic pathways highly associated to glpK mutation, we performed RNA-Seq analysis of SC and LC variants with different genetic M. tuberculosis backgrounds, namely the SC strain TDR193-SC and the LC strain TDR193-SC-RevLC9 (lineage 4, Euro/American family), and the HN878-SC and HN878-LC strains (lineage 2, Beijing family), both in the absence and presence of glycerol. In both M. tuberculosis strain backgrounds, the SCs showed gene expression patterns similar to that of the LCs in the absence of glycerol ( Fig. 5A ). By contrast, the LCs cultured in the presence of glycerol differed by coordinated expression changes associated with responses typically associated with adaptation to diverse stressors. For example, several stress response regulons, including SigH (28) and DosR (29) , were upregulated in the SCs with or without glycerol, relative to the LC strains in glycerol, while KstR (30) (31) than is observed in C57BL/6 mice (32) . Glycerol was detectable in normally appearing lung tissue (61.6 µg/ml), lung tissue with cellular infiltrates (44.13 µg/ml) as well as in lung caseum (10.4 µg/ml), with ~10 to 30% of the glycerol extracted from triglycerides. These results suggest in vivo M. tuberculosis infections may be exposed to glycerol that may both stimulate increased growth in wild type glpK variants, and also select for glpK mutants where slower growth or drug-tolerance may improve survival.
Discussion
Drug resistant M. tuberculosis has long been thought of as a stable phenotype that occurs through acquisition of heritable mutations. In contrast, drug-tolerance and drug-persistence have been viewed as reversible phenomena associated with transient phenotypic states. Here, we show in clinical strains of M. tuberculosis a novel type of drug-tolerance that is caused by a rapidly reversible glpK frameshift mutation in a 7C HT sequence, which produces a phenotype that is similar to the traditional definition of drug-tolerance (26, 27) . These tolerance-conferring frameshifts also slow bacterial growth and produce small colonies. The glpK mutant small colonies showed small but significant increases in survival following exposure to various antituberculosis agents, compared to glpK wild-type large colonies. Although these increases are small, such differences were consistent across different genetic M. tuberculosis backgrounds.
The association between genotypic drug-tolerance and slow growth, combined with a rapid reversal rate has potentially far reaching consequences, in that this process can mimic a drug-tolerant or persistent phenotype. For example, in the case of TB relapse the development of reversible drug-tolerance during TB treatment could permit a slow-growing bacterial subpopulation to survive drug treatment while causing minimal clinical symptoms. With the lifting of drug pressure at the end of treatment, the slow-growing population could rapidly revert to a wild-type population with the capacity to overgrow any drug-tolerant small colony cells, making the drug-tolerant subpopulation difficult to detect by conventional microbiological methods unless specifically assessed as in this study. Relapse in such a patient would thus be attributed to re-growth of a (drug-susceptible) "persister" population rather than genotypic drugtolerant mycobacteria. Our findings are supported by a previous study that identified glpK frameshift mutations in a screen for mutations that increase tolerance to streptomycin and rifampicin in M. tuberculosis (13) . Also demonstrating the potential clinical impact of even small changes in MIC, a recent study showed that increases as little as 0.01 µg/ml INH or RIF MIC in fully drug-susceptible M. tuberculosis isolates substantially raised the odds ratio for clinical relapse after TB treatment (33) .
Our discovery that drug-tolerance is linked to slow growth and glycerol metabolism suggests an important role for nutritionally controlled differences in growth rates in TB pathogenesis. Earlier studies have shown that M. tuberculosis growth is strongly enhanced by adding glycerol to the culture medium compared to carbon sources such as glucose or free fatty acids. This has led to the use of glycerol in all standard mycobacterial media (34) . Upon uptake, glycerol is phosphorylated by GlpK to glycerol-3-phosphate, which is either utilized for the synthesis of glycerophospholipids (35) or alternatively is converted by glycerol-3-phosphate dehydrogenase to dihydroxyacetone phosphate, which then enters glycolysis and gluconeogenesis (36) . Furthermore, GlpK belongs to the ROK (repressor, open-reading frame, kinase) protein family(37); therefore, it is also possible that GlpK (as shown for other sugar kinases (38) ), might also moonlight as a transcription regulator. When M. tuberculosis is starved for glycerol by either frameshifting glpK or by depleting glycerol from the medium, we suggest that a general stress response is activated, which phenotypically renders M. tuberculosis broadly stress resistant and antibiotic-tolerant. The RNA expression pattern that we noted to be part of this nutrient-limited stress response appears to be similar to that reported for wild-type M.
tuberculosis cultured under conditions that have been associated with a "tolerant" "persistent" state (29) . Culture of the LC but not the SC in rich glycerol media caused LCs to increase their growth rate. This increased growth and the accompanying down-regulation of stress regulons typified by DosR and SigH may have made the LC cultures more broadly susceptible to drugs and hydrogen peroxide. Therefore, M. tuberculosis appears to induce a general stress response by toggling on and off the expression of the glpK gene via reversible frameshifts within a 7C HT sequence.
We noted that all of the SC glpK mutants were caused by frameshift mutations occurring at a 7C HT located within the coding region of glpK. HTs in MMR-deficient bacteria are known to present slippage sites for DNA polymerases (39, 40) , which produce frameshift mutations at high frequency (41, 42) . M. tuberculosis also lacks a recognizable MMR system (21, 22) . genomes in the NCBI database found at least one frameshift mutation in 74% of these homopolymeric sequences (SI Appendix, Table S2 ). However, this mutational mechanism to our knowledge has not been previously reported as a cause of reversible drug-tolerance. Previous studies of numerous pathogenic bacteria such as Neisseria species, Mycoplasma species, and M.
abscessus have described the occurrence of frameshift mutations via slipped-strand mispairing in regions even without homopolymeric sequences(18, 43, 44) . These findings suggest that reversible frameshift mutations as a means of genetically regulating stress responses, including antibiotic tolerance, may be widespread in multiple organisms including M. tuberculosis.
We showed that glpK frameshifted SCs develop during murine infections and that selection increases further with drug treatment. Our study was performed in mice receiving a single drug (MXF), because drug tolerant M. tuberculosis in human TB is likely to develop in diseased lesions where poor drug penetration often results in effective monotherapy (45) . We found that glpK 7C HT variants emerged at a high rate under this circumstance. Pethe et al.
showed that pyrimidine-imidazoles (PIs), whose mechanism of action is linked to glycerol metabolism do not inhibit M. tuberculosis infection in a murine model (46) . However, the relative proportion of LC and SC generated in PI treated mice was not noted or recorded (46) . We suspect that it is possible that PI treatment provided a strong selection for the emergence of glpK mutants in these mice. Variants with glpK frameshift mutations are detectable in sputum samples from many human TB patients and, furthermore, these glpK mutants were unstable (47, 48) .
Human plasma and mouse lung tissue contain significant amounts of free-glycerol(49-52) and our results show that free glycerol is also present in diseased mouse lung and caseum. The levels of glycerol we detected in vivo are substantially lower than those used in M. tuberculosis culture medium. While the level of glycerol needed to promote a growth difference between WT and glpK mutants in vivo is unknown, we have shown that the in vivo environment provides strong selection for glpK mutations. Overall, our results strongly suggest that SC emergence and drugtolerance caused by GlpK phase variation is relevant in human TB. We also suggest that a larger Deletion of glpK gene from M. tuberculosis H37Rv strain. The glpK gene was deleted using allelic exchange techniques as described previously (54) . Briefly, 1500 base pairs upstream and downstream of glpK were cloned into p2NIL suicide vector containing lacZ-sacB selection cassette. All cloning were done in E.coli XL10 Gold (Aglient) and the final mutant construct was confirmed by Sanger sequencing. H37Rv strain was transformed with the final mutant construct followed by two-step selection process, as described previously (54) . The glpK deletion was screened by PCR and confirmed by whole genome sequence as described below.
To complement the glpK deletion with the gene transcribed from its own promoter, a determined by the microdilution method, as described previously (55, 56) . Briefly, the first column of wells of a 96-well plate (Costar) was filled with 200µl of 7H9 containing the drug at maximum concentration to be tested. The remaining wells were filled with 100µl 7H9 medium.
This was used to perform 2-fold serial dilution of the drugs, RIF 0.82-->0.003µg/ml, INH 0.34-->0.0027µg/ml and MXF 1-->0.008µg/ml. Each well was inoculated with approximately 5x10 5 CFU of M. tuberculosis. Plates were sealed with a Breathe-Easy membrane (Sigma) and incubated at 37C and shaking for 10 days. The percentage of growth inhibition in each well was determined by measuring optical density at 600nm (OD600) in a Cytation 3 Imaging plate Reader (BioTek Instruments) and comparing it to a well with no drug. The susceptibility tests were done in triplicate and statistical significance was analyzed using a two-way ANOVA. Susceptibility of M. bovis BCG strains to POA in 7H9 broth at near-neutral pH 6.5 (with 0.5% (vol / vol) or without glycerol) was determined as described previously (53) . POA MIC50 values reported here are those concentrations of drug that inhibit 50% of growth as compared to a drug-free control after 5 days of incubation. The wild-type strain was included as a control in all experiments. All MICs were performed in three technical and biological replicates.
Reversion of the small colony phenotype to wild-type colony phenotype. Three independent colonies from small colony phenotype cultures were randomly picked and grown in 7H9 liquid medium at 37°C to late phase (OD580 =1.6), which was considered passage 0.
Each culture was plated on 7H10 agar medium and the frequency of large colonies was determined. The cultures were then diluted to 8.69 × 10 7 ± 2.20 × 10 7 CFU per starting inoculum, and flasks of 12ml 7H9 liquid medium were inoculated. The culture flasks were incubated at 37°C for 1 week. Serial dilutions of the cultures were plated on 7H10 agar medium to determine the CFU count and to examine the emergence of large-colony phenotypes. The culture passages were repeated up to 12 times. Variants falling in PE/PPE family genes were excluded from the analysis.
RNA extraction, library preparation, and sequencing. M. tuberculosis strains were grown to mid-log phase (OD600 =0.6-0.7) at 37°C in 7H9 medium with or without 1% glycerol.
Total RNA was extracted by using Trizol reagents (Invitrogen) as described previously (59) . The The aligned reads were obtained using the following parameters: maximum number of allowed mismatches was 2, minimum length and similarity fraction was set at 0.8, and minimum number of hits per read was 10. For each strain three independent RNA extractions and RNAseq analysis were performed; and the statistical analysis of differentially expressed genes compared to the control strain is carried out based on a negative binomial GLM model influenced by the multifactorial EdgeR method(60), a tool in CLC Genomic Workbench.
We ranked RPKM expression values for each sample, such that the lowest RPKM value was designated 1, the second lowest value was designated 2, etc. We used these ranked values as input into the Gene Set Enrichment Analysis (GSEA) Pipeline (http://software.broadinstitute.org/gsea/index.jsp) (61) . Using the GSEA analysis software, we tested for enrichment in gene sets based on regulons (information from TFOE (62)). The genes were ranked ordered by the GSEA software according to their ranked RPKM values using the Student's t statistic metric assessing difference between conditions compared. Gene sets compromising activated and repressed targets genes were analyzed separately, and sets consisting of greater than 10 genes were included in the analysis, and nominal p-values calculated from the analyses of the activated and repressed genes were combined using Fisher's method (63) . A "regulon activity change score" was calculated by weighting the gene-set-size- Glycerol quantitation in infected lung tissue. Lung tissues were cryosectioned to 25 µm thick and 3,000,000 µm 2 of sectioned tissue was collected by laser capture microdissection using a Leica LMD 6500 (64) . Extraction was performed by adding 50µL of acetonitrile to 3,000,000 µm 2 of 25 µm thick laser captured tissue. Extracts were sonicated in a water batch for 10minutes and centrifuged at 4000 RPM for 5 minutes. Examples of small colonies are indicated by red arrows and large colonies by black arrows. 
